These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33957143)

  • 1. Treating heart failure in patients with diabetes: The view of the cardiologist.
    Kumowski N; Marx N; Schütt K
    Diabetes Res Clin Pract; 2021 Jun; 176():108852. PubMed ID: 33957143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes in Patients With Heart Failure With Reduced Ejection Fraction During Hospitalization: A Retrospective Observational Study.
    Zhou Y; Wang M; Wang S; Li N; Zhang S; Tang S; Shi Q; Zhao Y; Li J; Zeng Y; Song H; Tian H; Li S; Li S
    Front Endocrinol (Lausanne); 2021; 12():727188. PubMed ID: 34456878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.
    Arnold SV; Yap J; Lam CSP; Tang F; Tay WT; Teng THK; McGuire DK; Januzzi JL; Fonarow GC; Masoudi FA; Kosiborod M
    Diabetes Obes Metab; 2019 Feb; 21(2):261-266. PubMed ID: 30136348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction.
    Paulus WJ; Dal Canto E
    JACC Heart Fail; 2018 Jan; 6(1):1-7. PubMed ID: 29284577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with normal ejection fraction. Pathophysiology, diagnosis, and treatment.
    Tschöpe C; Westermann D
    Herz; 2009 Mar; 34(2):89-96. PubMed ID: 19370324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry.
    Patel N; Ju C; Macon C; Thadani U; Schulte PJ; Hernandez AF; Bhatt DL; Butler J; Yancy CW; Fonarow GC
    JACC Heart Fail; 2016 May; 4(5):348-56. PubMed ID: 26874392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialty-Based Variability in Diagnosing and Managing Heart Failure With Preserved Ejection Fraction.
    Saxon DT; Kennel PJ; Guyer HM; Goyal P; Hummel SL; Konerman MC
    Mayo Clin Proc; 2020 Apr; 95(4):669-675. PubMed ID: 32247341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Schöpe J; Wagenpfeil S; Tavazzi L; Böhm M; Ponikowski P; Anker SD; Filippatos GS; Cowie MR;
    Eur J Heart Fail; 2019 Jul; 21(7):921-929. PubMed ID: 30933403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry.
    Echouffo-Tcheugui JB; Xu H; DeVore AD; Schulte PJ; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Heidenreich PA; Fonarow GC
    Am Heart J; 2016 Dec; 182():9-20. PubMed ID: 27914505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry.
    Komajda M; Cowie MR; Tavazzi L; Ponikowski P; Anker SD; Filippatos GS;
    Eur J Heart Fail; 2017 Nov; 19(11):1414-1423. PubMed ID: 28463464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program.
    Pokharel Y; Wei J; Hira RS; Kalra A; Shore S; Kerkar PG; Kumar G; Risch S; Vicera V; Oetgen WJ; Deswal A; Turakhia MP; Glusenkamp N; Virani SS
    Clin Cardiol; 2016 Mar; 39(3):145-9. PubMed ID: 26880649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
    Streng KW; Nauta JF; Hillege HL; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Zannad F; Damman K; van der Meer P; Voors AA
    Int J Cardiol; 2018 Nov; 271():132-139. PubMed ID: 30482453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Diabetes Obes Metab; 2019 Mar; 21(3):736-740. PubMed ID: 30447033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study.
    Bitar S; Agrinier N; Alla F; Rossignol P; Mebazaa A; Thilly N
    Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1489-1500. PubMed ID: 31339629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study.
    Iorio A; Senni M; Barbati G; Greene SJ; Poli S; Zambon E; Di Nora C; Cioffi G; Tarantini L; Gavazzi A; Sinagra G; Di Lenarda A
    Eur J Heart Fail; 2018 Sep; 20(9):1257-1266. PubMed ID: 29917301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.